Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers (Q45423782)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers |
scientific article |
Statements
1 reference
Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers (English)
1 reference
1 reference
Helen McShane
1 reference
Andrew J McMichael
1 reference
Lucy Dorrell
1 reference
Inese Cebere
1 reference
Sheena McCormack
1 reference
Claudia Schmidt
1 reference
Carol Smith
1 reference
Mary Brooks
1 reference
Joanna E Roberts
1 reference
Simon C Darwin
1 reference
Patricia E Fast
1 reference
Christopher Conlon
1 reference
Sarah Rowland-Jones
1 reference
Tomás Hanke
1 reference
24 August 2005
1 reference
Identifiers
1 reference